07/03/2025

The aim of the call is to support research that: - builds understanding of molecular and cellular mechanisms governing interactions between the heart and other organs during pathological state of either system; - builds comprehensive approaches to understanding cardiovascular disease interactions, combining basic research, clinical translation, and digital innovation through international collaboration; - enables transnational collaboration of multidisciplinary scientists (molecular and cellular biology including metabolic studies and (epi)-genetics, pharmacology, (patho-) physiology, clinical cardiology and other medical disciplines such as endocrinology, psychology, nephrology, oncology, immunology, etc.) from different countries to work together across borders, taking advantage of complementary expertise and leveraging diverse patient populations and sets of data.

ERA4Health Partnership The ERA4Health Partnership brings together 32 entities and 27 funding organisations from 21 countries, with the common goal of fostering high-impact translational research for addressing public health needs. Through cross-national joint calls for proposals and making the most of interregional and international cooperation, ERA4Health aims to provide influential contributions as well as a sustainable model of funding for ground-breaking translational research in the health domain across Europe and beyond. ERA4Health focuses on tackling diseases and reducing disease burden by addressing the following challenges: the increasing demand for a better quality of life and a better care of patients, the need to transform public health care systems in a more effective, efficient, equitable, accessible, and resilient ones, and the need to strengthen disease prevention and health promotion.

https://era4health.eu/